首页> 外文会议>IASTED international conference on biomedical engineering;BioMED 2010 >DOSIMETRIC EVALUATION FOR NEUTRON CAPTURE THERAPY TO HEPATOCELLULAR CARCINOMA USING INTRA-ARTERIAL ADMINISTRATION OF BORON-ENTRAPPED WATER-IN-OIL-IN-WATER EMULSION
【24h】

DOSIMETRIC EVALUATION FOR NEUTRON CAPTURE THERAPY TO HEPATOCELLULAR CARCINOMA USING INTRA-ARTERIAL ADMINISTRATION OF BORON-ENTRAPPED WATER-IN-OIL-IN-WATER EMULSION

机译:含硼油包水乳状液的动脉内给药对中子捕获治疗肝癌的剂量学评价

获取原文

摘要

Hepatocellular carcinoma (HCC) is one of the difficult to cure with combinational medical therapies. Tumour cell destruction in boron neutron capture therapy (BNCT) is due to the nuclear reaction between ~(10)B atoms and thermal neutrons, so it is necessary to accumulate efficient ~(10)B atoms to tumour cells for effective BNCT. We prepared ~(10)BSH entrapped Water-in-oil-in-water(WOW) emulsion for selective intra-arterial infusion to HCC, and performed preliminary dosimetry with Japan Atomic Research Institute Computational Dosimetry System using CTscan imaging of HCC patient. The ~(10)B concentrations in VX-2 tumour by WOW emulsion was superior to those by conventional emulsion. According to the rabbit model, the boron concentrations (ppm) of tumour, normal liver tissue, or blood is 61.7, 4.3, 0.1, respectively. In the epithermal lneutron dosimetry, the maximum tumour RBE dose, minimum tumour RBE dose, and mean tumour RBE dose are 43.1, 7.3, and 21.8 Gy-Eq, respectively, with the normal liver RBE restriction to 4.9 Gy, in 40 minutes irradiation. In this study, we showed that ~(10)B entrapped WOW emulsion would be applied to novel intra-arterial boron delivery carrier on BNCT to cancer, and, we showed the possibility to apply BNCT to HCC.
机译:肝细胞癌(HCC)是联合药物治疗难以治愈的疾病之一。硼中子俘获疗法(BNCT)中的肿瘤细胞破坏是由于〜(10)B原子与热中子之间的核反应所致,因此有必要将有效的〜(10)B原子积累到肿瘤细胞中以产生有效的BNCT。我们制备了〜(10)BSH包埋的水包油包水(WOW)乳剂,用于选择性地向HCC进行动脉内输注,并使用日本原子科学研究所计算剂量系统通过CTscan对HCC患者进行了初步剂量测定。 WOW乳剂在VX-2肿瘤中的〜(10)B浓度优于常规乳剂。根据兔子模型,肿瘤,正常肝组织或血液中的硼浓度(ppm)分别为61.7、4.3、0.1。在超热中子剂量测定中,在40分钟的辐照下,最大肿瘤RBE剂量,最小肿瘤RBE剂量和平均肿瘤RBE剂量分别为43.1、7.3和21.8 Gy-Eq,而正常肝脏RBE限制为4.9 Gy。在这项研究中,我们表明〜(10)B包埋的WOW乳剂可用于BNCT上新型的动脉内硼递送载体以治疗癌症,并且我们证明了将BNCT应用于HCC的可能性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号